Emerson Electric (EMR) concluded the recent trading session at $109.97, signifying a +0.47% move from its prior day's close.
Emerson Electric (EMR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Emerson (EMR) is set to gain from strength in the Intelligent Devices business segment and the acquisitions of Afag and Flexim. Its measures to reward its shareholders are noteworthy.
Emerson Electric has undergone significant transformation toward long-term high-margin growth, with a clearer focus on automation and software-centric offerings to a wide range of industries. Short-cycle industrial end-markets have been challenging, but Emerson is cautiously optimistic about a rebound and seems to be gaining share in some markets. Opportunities in longer-cycle process industries/markets like LNG and hydrogen remain very attractive.
While the Dividend Aristocrats group is a favorite among income investors, a step above is the elite Dividend Kings group.
Emerson Electric (EMR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Emerson Electric (EMR) concluded the recent trading session at $108.53, signifying a +0.03% move from its prior day's close.
Emerson Electric (EMR) reported earnings 30 days ago. What's next for the stock?
Emerson Electric (EMR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
From a technical perspective, Emerson Electric (EMR) is looking like an interesting pick, as it just reached a key level of support. EMR recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
Positive: Increased capital investment is driving revenue & EPS above historic trend rates. Negative: Continues ¨Portfolio¨ M&A has flat-lined cash flow and cut into ROIC. Consensus valuation of US$128 (+13%) backs into a target P/E of 23x and 1.5x P/E that seems reasonable.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?